Acasti Pharma Inc
XTSX:ACST
Acasti Pharma Inc
XTSX:ACST
Price:
0.58
CAD
1.75%
Market Closed
Market Cap:
CA$25.9m
Cash Flow Statement
Cash Flow Statement
Acasti Pharma Inc
Acasti Pharma Inc
Currency: USD
| Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(20)
|
(10)
|
(42)
|
|
| Depreciation & Amortization |
1
|
0
|
0
|
|
| Other Non-Cash Items |
10
|
(5)
|
26
|
|
| Change in Working Capital |
(6)
|
(3)
|
0
|
|
| Cash from Operating Activities |
(14)
N/A
|
(17)
-20%
|
(16)
+8%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
|
| Other Items |
(10)
|
(4)
|
13
|
|
| Cash from Investing Activities |
(10)
N/A
|
(4)
+64%
|
13
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
60
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
59
N/A
|
0
N/A
|
0
N/A
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
1
|
0
|
(0)
|
|
| Net Change in Cash |
37
N/A
|
(21)
N/A
|
(2)
+88%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(14)
N/A
|
(17)
-20%
|
(16)
+8%
|
|
Switch to:
Switch to:
See Also
Discover More
